Skip Nav Destination
Issues
1 August 2010
-
Cover Image
Cover Image
![issue cover]()
CXC chemokine receptor 2 (CXCR2) expression in an ovarian cancer cell line detected by the immunofluorescent staining. Overexpression of CXCR2 in ovarian cancer cells leads to dysregulation of cell cycle, decreased apoptosis, and increased angiogenesis. The high level expression of CXCR2 also predicts poor prognosis in patients with high-grade ovarian serous carcinoma. For further details, please see the article by Yang and colleagues on page 3875 of this issue.Close Modal - PDF Icon PDF LinkTable of Contents
ISSN 1078-0432
EISSN 1557-3265
Highlights
CCR New Strategies
CCR Translations
Molecular Pathways
Predictive Biomarkers and Personalized Medicine
Human Cancer Biology
Cancer Therapy: Preclinical
The Combination of a Histone Deacetylase Inhibitor with the Bcl-2 Homology Domain-3 Mimetic GX15-070 Has Synergistic Antileukemia Activity by Activating Both Apoptosis and Autophagy
Yue Wei; Tapan Kadia; Weigang Tong; Ming Zhang; Yu Jia; Hui Yang; Yumin Hu; Francesco Paolo Tambaro; Jean Viallet; Susan O'Brien; Guillermo Garcia-Manero
Metabolic Approach to the Enhancement of Antitumor Effect of Chemotherapy: a Key Role of Acetyl-l-Carnitine
Claudio Pisano; Loredana Vesci; Ferdinando Maria Milazzo; Mario Berardino Guglielmi; Rosanna Foderà; Marcella Barbarino; Maurizio D'Incalci; Massimo Zucchetti; Giovanna Petrangolini; Monica Tortoreto; Paola Perego; Valentina Zuco; Augusto Orlandi; Daniela Passeri; Paolo Carminati; Claudio Cavazza; Franco Zunino
Imaging, Diagnosis, Prognosis
Genetically Abnormal Circulating Cells in Lung Cancer Patients: An Antigen-Independent Fluorescence In situ Hybridization–Based Case-Control Study
Ruth L. Katz; Weigong He; Abha Khanna; Ricardo L. Fernandez; Tanweer M. Zaidi; Matthew Krebs; Nancy P. Caraway; Hua-Zhong Zhang; Feng Jiang; Margaret R. Spitz; David P. Blowers; Carlos A. Jimenez; Reza J. Mehran; Stephen G. Swisher; Jack A. Roth; Jeffrey S. Morris; Carol J. Etzel; Randa El-Zein
Cancer Therapy: Clinical
Phase II Trial of Short-Course R-Chop Followed by 90Y-Ibritumomab Tiuxetan in Previously Untreated High-Risk Elderly Diffuse Large B-Cell Lymphoma Patients
Pier Luigi Zinzani; Giuseppe Rossi; Silvia Franceschetti; Barbara Botto; Alice Di Rocco; Maria Giuseppina Cabras; Maria Concetta Petti; Vittorio Stefoni; Alessandro Broccoli; Stefano Fanti; Cinzia Pellegrini; Gian Carlo Montini; Letizia Gandolfi; Enrico Derenzini; Lisa Argnani; Mariapaola Fina; Alessandra Tucci; Chiara Bottelli; Stefano Pileri; Michele Baccarani
Phase I/II Study of Oncolytic HSVGM-CSF in Combination with Radiotherapy and Cisplatin in Untreated Stage III/IV Squamous Cell Cancer of the Head and Neck
Kevin J. Harrington; Mohan Hingorani; Mary Anne Tanay; Jennifer Hickey; Shreerang A. Bhide; Peter M. Clarke; Louise C. Renouf; Khin Thway; Amen Sibtain; Iain A. McNeish; Kate L. Newbold; Howard Goldsweig; Robert Coffin; Christopher M. Nutting
Inhaled Granulocyte-Macrophage Colony Stimulating Factor for First Pulmonary Recurrence of Osteosarcoma: Effects on Disease-Free Survival and Immunomodulation. A Report From the Children's Oncology Group
Carola A.S. Arndt; Nadya V. Koshkina; Carrie Y. Inwards; Douglas S. Hawkins; Mark D. Krailo; Doojduen Villaluna; Peter M. Anderson; Allen M. Goorin; Martin L. Blakely; Mark Bernstein; Sharon A. Bell; Kaylee Ray; Darryl C. Grendahl; Neyssa Marina; Eugenie S. Kleinerman
Patients with Advanced Head and Neck Cancers Have Similar Progression-Free Survival on Phase I Trials and Their Last Food and Drug Administration–Approved Treatment
Ignacio Garrido-Laguna; Filip Janku; Gerald S. Falchook; Siqing Fu; David S. Hong; Aung Naing; Joanne Aaron; Xuemei Wang; Merrill Kies; Razelle Kurzrock
Immunologic Response to Xenogeneic gp100 DNA in Melanoma Patients: Comparison of Particle-Mediated Epidermal Delivery with Intramuscular Injection
Brian A. Ginsberg; Humilidad F. Gallardo; Teresa S. Rasalan; Matthew Adamow; Zhenyu Mu; Sapna Tandon; Barrett B. Bewkes; Ruth-Ann Roman; Paul B. Chapman; Gary K. Schwartz; Richard D. Carvajal; Katherine S. Panageas; Stephanie L. Terzulli; Alan N. Houghton; Jianda D. Yuan; Jedd D. Wolchok
Advertisement
